South Korea receives their first shipment of Pfizer's Paxlovid anti-COVID-19 oral drug.

Sources: AP

Changes

South Korea receives the first shipment of the Pfizer's Paxlovid anti-COVID-19 oral drug to treat 21,000 people for five days.
2022-01-14 01:05:59 (First version)
South Korea receives their first shipment of Pfizer's Paxlovid anti-COVID-19 oral drug.
(Current version)